Analytical Data
-
基因名
EGF
- Application
-
别名
EGF；Pro-epidermal growth factor
-
种属
Human
-
表达系统
E. coli
-
标签
N-terminal His Tag
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P18846
-
表达区间
609~751aa
-
氨基酸序列
AKRLFWTDTGINPRIESSSLQGLGRLVIASSDLIWPSGITIDFLTDKLYWCDAK QSVIEMANLDGSKRRRLTQNDVGHPFAVAVFEDYVWFSDWAMPSVMRVNKRTGK DRVRLQGSMLKPSSLVVVHPLAKPGADPCLYQNGG
-
分子量
17.3kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Identification
Protein Description
Epidermal growth factor (EGF) is a key peptide involved in cell growth, proliferation, and differentiation, making it a critical element in various biological processes. The study of recombinant EGF protein has gained traction due to its potential applications in regenerative medicine, wound healing, and cancer therapy. Recombinant technology allows for the expression of EGF in a controlled manner, enabling the production of high-purity and active forms of the protein. Understanding its role in cellular signaling pathways has opened avenues for therapeutic interventions, as EGF can influence epithelial cell behavior and tissue repair mechanisms. Moreover, advancements in biotechnology have enhanced the ability to produce this protein efficiently, reducing costs and improving availability for research and clinical applications. As EGF's significance in dermatology and oncology becomes more apparent, ongoing research focuses on optimizing its formulation and delivery methods to maximize efficacy while minimizing side effects. The integration of EGF in various therapeutic strategies continues to be a promising area of exploration in biotechnology and medicine.
